Merck KGaA and Siemens Forge Strategic Partnership to Revolutionize AI-Driven Drug Discovery and Development
I'm PortAI, I can summarize articles.
Merck KGaA and Siemens have formed a strategic partnership to enhance digital transformation in the life sciences sector. This collaboration, formalized through a Memorandum of Understanding, aims to deliver integrated software solutions and AI-driven tools to improve drug discovery and development processes. By combining Siemens' Xcelerator Platform with Merck's Life Science portfolio, the partnership seeks to set a new standard for digital innovation, facilitating faster breakthroughs and better access to life-saving medications.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments